CAD & Atherosclerosis
Feature
How to Reduce Cardiovascular Morbidity and Mortality in Psoriasis and PsA
Experts take a look at the landscape of why and how dermatologists and rheumatologists ought to play a more consistent and active role in primary...
From the Journals
Alcohol and CV Risk: Both Beneficial and Harmful Effects?
The answer may depend on the presence of circulating metabolites of alcohol, some of which may be beneficial while others may be harmful.
Latest News
Erectile Dysfunction Rx: Give It a Shot
As physicians, we must do a better job of talking to our patients about ED and letting them know that it’s a marker for overall health.
Feature
GLP-1 RAs for CVD: Are cardiologists ready?
“I definitely see increasing adoption of GLP-1 RAs by cardiologists and expect the number to increase now that the data support its use in...
From the Journals
Younger heart disease onset tied to higher dementia risk
The findings suggest “additional attention should be paid to the cognitive status of patients with CHD, especially the ones diagnosed with CHD at...
Latest News
Statin use remains low for at-risk patients
Statin usage increased since 1999 but peaked at 35% in 2013 despite expanded ACC/AHA guidelines.
Latest News
Smoking alters salivary microbiota in potential path to disease risk
"Decreased microbial nitrate reduction pathway abundance in smokers may provide an additional explanation for the effect of smoking on...
From the Journals
PTSD symptoms in women tied to worse heart, brain health
Outcomes of interest were associations of PTSD symptoms with carotid intima media thickness, brain white matter hyperintensity volume, and...
From the Journals
Long-term use of ADHD meds and CVD risk: New data
“Clinicians should be vigilant in monitoring signs and symptoms of cardiovascular diseases, particularly among those receiving higher doses.”
Conference Coverage
AI interpretation of CCTA unlocks value of inflammation as CV risk factor
Combined with imaging, artificial intelligence (AI) identifies risk in setting of nonobstructive coronary disease.
Latest News
PREVENT: AHA’s new risk calculator incorporates CKM health
PREVENT is for use in adults aged 30-79 years and estimates the 10- and 30-year risk of total CVD including, for the first time, heart failure.